Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Tumour”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00935870
What this trial is testing

Bioactive Glass as Bone Graft Substitute in Operative Treatment of Bone - a 10 Years Follow-up Study

Who this might be right for
Depressed Lateral Condyle FractureBenign Bone Tumour CavitySpinal Fusion
Vivoxid Ltd 63
Testing effectiveness (Phase 2)Study completedNCT01817751
What this trial is testing

Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma

Who this might be right for
GlioblastomaRecurrent Adult Brain NeoplasmMalignant Glioma+1 more
Virginia Commonwealth University 47
Early research (Phase 1)Study completedNCT00078637
What this trial is testing

Dosing and Safety Study of E7820 in Patients With a Malignant Solid Tumor or Lymphoma

Who this might be right for
NeoplasmsLymphoma, Malignant
Eisai Inc. 37
Large-scale testing (Phase 3)UnknownNCT02531841
What this trial is testing

High-dose Chemotherapy and ASCT or Consolidating Conventional Chemotherapy in Primary CNS Lymphoma

Who this might be right for
Diffuse Large B-cell-lymphoma
University Hospital Freiburg 250
Not applicableActive Not RecruitingNCT05677594
What this trial is testing

Multi-parametric Biomarker Development to Predict Malignant Conversion in Patients With Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis 1Malignant Peripheral Nerve Sheath Tumor (MPNST) of Soft Tissue (Diagnosis)Atypical Neurofibroma
Johns Hopkins University 80
Not applicableEnded earlyNCT03971266
What this trial is testing

Movement and Fitness Trackers in Determining Performance Status

Who this might be right for
Malignant Neoplasm
University of Southern California 31
Not applicableEnded earlyNCT04556929
What this trial is testing

Enhanced Detection in Glioma Excision

Who this might be right for
Glioma
University of Oxford 4
Not applicableUnknownNCT03979339
What this trial is testing

Feasibility of a New Technology for Isolating Circulating Tumour Cells

Who this might be right for
HER2-positive Metastatic Breast CancerOvarian CancerHormone-resistant Prostate Cancer+1 more
Centre Oscar Lambret 76
Testing effectiveness (Phase 2)Study completedNCT01378975
What this trial is testing

Vemurafenib in Metastatic Melanoma Participants With Brain Metastases

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 146
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07714395
What this trial is testing

Evaluate Preliminary Anti-tumor Activity of Elraglusib in Adult Participants With Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
Actuate Therapeutics Inc. 100
Not applicableStudy completedNCT03146624
What this trial is testing

Evaluation of Patients Satisfaction of Attachment Retained Versus Clasp Retained Obturators in Unilateral Total Maxillectomy

Who this might be right for
Tumour
Cairo University 14
Not applicableUnknownNCT00264056
What this trial is testing

Efficacy of Chemotherapy Combined With Regional Hypothermia in Advanced Malignant Melanoma Patients With Progressive Soft Tissue Metastases

Who this might be right for
Advanced Metastastic Malignant MelanomaRefractory to First-Line Chemotherapy Irresectable Progressive Soft Tissue Metastases
Fachklinik Hornheide an der Universität Münster 26
Not applicableLooking for participantsNCT06314672
What this trial is testing

Outreach Project to Connect Underrepresented Populations to Clinical Trials at Ohio State University, CUSP2CT Project Trial

Who this might be right for
Hematopoietic and Lymphoid System NeoplasmMalignant Solid Neoplasm
Ohio State University Comprehensive Cancer Center 208
Testing effectiveness (Phase 2)Ended earlyNCT02923739
What this trial is testing

Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube AdenocarcinomaFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid Adenocarcinoma+17 more
M.D. Anderson Cancer Center 9
Early research (Phase 1)Active Not RecruitingNCT06459869
What this trial is testing

NG-350A Plus Chemoradiotherapy for Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer (LARC)
Akamis Bio 30
Testing effectiveness (Phase 2)Looking for participantsNCT07680205
What this trial is testing

An Experimental Study of Belzutifan Impact on Catecholamine Metabolism

Who this might be right for
Pheochromocytoma and Paraganglioma (PPGL)Pheochromocytoma MalignantPheochromocytoma, Metastatic+2 more
Cambridge University Hospitals NHS Foundation Trust 12
Not applicableUnknownNCT05617105
What this trial is testing

Molecular Characterization of Perivascular Epithelioid Cell Tumors

Who this might be right for
Perivascular Epithelioid Cell Tumor, Malignant
University Hospital, Strasbourg, France 100
Testing effectiveness (Phase 2)Looking for participantsNCT06172595
What this trial is testing

FET PET in Differentiating Tumour Progression From Pseudoprogression in High Grade Glioma

Who this might be right for
Glioma, Malignant
Singapore General Hospital 22
Not applicableLooking for participantsNCT04095195
What this trial is testing

Registry of Subjects at Risk of Pancreatic Cancer

Who this might be right for
Familial Pancreatic CancerBRCA1 MutationBRCA2 Mutation+4 more
Associazione Italiana per lo Studio del Pancreas 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT07399769
What this trial is testing

Efficacy and Safety of MSLN CAR-T in Advanced Malignant Tumors

Who this might be right for
Advanced Solid Malignant Tumors (With Positive Expression of MSLN in Tumor Tissue)
Shenzhen University General Hospital 20
Next Page